Renaissance Technologies's IRMD Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 456,412 shares of IRADIMED CORPORATION (IRMD) worth $44.4 M, representing 0.07% of the portfolio. First purchased in 2016-Q3, this long-term strategic position has been held for 38 quarters.
Based on 13F filings, Renaissance Technologies has maintained a strategic position in IRMD, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2018, adding 121,800 shares. Largest reduction occurred in Q3 2022, reducing 46,066 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's IRADIMED CORPORATION (IRMD) Holding Value Over Time
Track share changes against reported price movement
Quarterly IRADIMED CORPORATION (IRMD) Trades by Renaissance Technologies
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -32,350 | Reduce 6.62% | 456,412 | $97.28 |
| Q3 2025 | -3,050 | Reduce 0.62% | 488,762 | $71.16 |
| Q2 2025 | -9,900 | Reduce 1.97% | 491,812 | $59.79 |
| Q1 2025 | -11,300 | Reduce 2.20% | 501,712 | $52.48 |
| Q4 2024 | -26,486 | Reduce 4.91% | 513,012 | $55.00 |
| Q3 2024 | -20,714 | Reduce 3.70% | 539,498 | $50.29 |
| Q2 2024 | -13,032 | Reduce 2.27% | 560,212 | $43.94 |
| Q1 2024 | -6,968 | Reduce 1.20% | 573,244 | $43.99 |
| Q4 2023 | +5,300 | Add 0.92% | 580,212 | $47.47 |
| Q3 2023 | -7,500 | Reduce 1.29% | 574,912 | $44.37 |
| Q2 2023 | +1,800 | Add 0.31% | 582,412 | $0.05 |
| Q1 2023 | -13,700 | Reduce 2.31% | 580,612 | $0.04 |
| Q4 2022 | -32,200 | Reduce 5.14% | 594,312 | $0.03 |
| Q3 2022 | -46,066 | Reduce 6.85% | 626,512 | $30.06 |
| Q2 2022 | -734 | Reduce 0.11% | 672,578 | $33.94 |
| Q1 2022 | -20,000 | Reduce 2.88% | 673,312 | $44.84 |
| Q4 2021 | -9,400 | Reduce 1.34% | 693,312 | $46.21 |
| Q3 2021 | +400 | Add 0.06% | 702,712 | $33.59 |
| Q2 2021 | -21,302 | Reduce 2.94% | 702,312 | $29.41 |
| Q1 2021 | -14,543 | Reduce 1.97% | 723,614 | $25.77 |
| Q4 2020 | +13,600 | Add 1.88% | 738,157 | $22.80 |
| Q3 2020 | +38,200 | Add 5.57% | 724,557 | $21.38 |
| Q2 2020 | +60,200 | Add 9.61% | 686,357 | $23.21 |
| Q1 2020 | +91,789 | Add 17.18% | 626,157 | $21.35 |
| Q4 2019 | +117,268 | Add 28.12% | 534,368 | $23.38 |
| Q3 2019 | +53,700 | Add 14.78% | 417,100 | $21.02 |
| Q2 2019 | +17,200 | Add 4.97% | 363,400 | $20.45 |
| Q1 2019 | +25,700 | Add 8.02% | 346,200 | $28.09 |
| Q4 2018 | +121,800 | Add 61.30% | 320,500 | $24.46 |
| Q3 2018 | +81,500 | Add 69.54% | 198,700 | $37.15 |
| Q2 2018 | +63,742 | Add 119.24% | 117,200 | $20.75 |
| Q1 2018 | +5,688 | Add 11.91% | 53,458 | $14.40 |
| Q4 2017 | +31,870 | Add 200.44% | 47,770 | $15.16 |
| Q3 2017 | +15,900 | New Buy | 15,900 | $9.62 |
| Q2 2017 | -18,618 | Sold Out | 0 | $0.00 |
| Q1 2017 | -7,682 | Reduce 29.21% | 18,618 | $8.92 |
| Q4 2016 | -19,600 | Reduce 42.70% | 26,300 | $11.10 |
| Q3 2016 | +45,900 | New Buy | 45,900 | $16.99 |
Renaissance Technologies's IRADIMED CORPORATION Investment FAQs
Renaissance Technologies first purchased IRADIMED CORPORATION (IRMD) in Q3 2016, acquiring 45,900 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held IRADIMED CORPORATION (IRMD) for 38 quarters since Q3 2016.
Renaissance Technologies's largest addition to IRADIMED CORPORATION (IRMD) was in Q4 2018, adding 320,500 shares worth $7.84 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 456,412 shares of IRADIMED CORPORATION (IRMD), valued at approximately $44.4 M.
As of the Q4 2025 filing, IRADIMED CORPORATION (IRMD) represents approximately 0.07% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies's peak holding in IRADIMED CORPORATION (IRMD) was 738,157 shares, as reported at the end of Q4 2020.